Efficacy and safety of atorvastatin in hyperlipidemic, type 2 diabetic patients. A 34-week, multicenter, open-label study.
Aguilar-Salinas CA, Gómez-Pérez FJ, Posadas-Romero C, Vázquez-Chávez C, Meaney E, Gulías-Herrero A, Guillén LE, Alvarado Vega A, Mendoza Pérez E, Eduardo Romero-Nava L, Angélica Gómez-Díaz R, Salinas-Orozco S, Moguel R, Novoa G.
Aguilar-Salinas CA, et al. Among authors: mendoza perez e.
Atherosclerosis. 2000 Oct;152(2):489-96. doi: 10.1016/s0021-9150(99)00502-x.
Atherosclerosis. 2000.
PMID: 10998478
Clinical Trial.